MEDDX | MEDGX | MEDDX / MEDGX | |
Total Expense Ratio | 1.81 | 0.81 | 223% |
Annual Report Gross Expense Ratio | 1.82 | 0.82 | 222% |
Fund Existence | 17 years | 17 years | - |
Gain YTD | 2.365 | 2.794 | 85% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.11B | 7.11B | 100% |
Annual Yield % from dividends | 5.68 | 6.69 | 85% |
Returns for 1 year | 6.23 | 7.31 | 85% |
Returns for 3 years | 16.42 | 19.88 | 83% |
Returns for 5 years | 6.03 | 11.52 | 52% |
Returns for 10 years | 25.55 | 38.84 | 66% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VSFRX | 22.63 | 0.38 | +1.71% |
Federated Hermes Clover Small Value R | |||
FGINX | 15.51 | 0.21 | +1.37% |
Macquarie Growth and Income A | |||
MXLSX | 36.60 | 0.48 | +1.33% |
Empower Small Cap Value Inv | |||
FSZIX | 9.79 | 0.01 | +0.10% |
Fidelity Advisor Sustainable EM Eq I | |||
DISRX | 24.03 | N/A | N/A |
BNY Mellon International Stock Fund I |